Table 3.
Hematological parameters
|
Group A |
Group B |
|||
| Basal | 4 wk | Basal | 4 wk | |
| Haemoglobin (g/100 mL) | 14.28 | 13.98 | 13.81 | 13.79 |
| Haematocrit (g/100 mL) | 42.55 | 42.01 | 40.50 | 40.61 |
| Erythrocytes (× 106/mm3) | 4.81 | 4.69 | 4.60 | 4.58 |
| Platelet count (× 103/mm3) | 232.95 | 249.84 | 263.22 | 260.50 |
| VSG (mm/h) | 17.13 | 15.00 | 19.60 | 17.38 |
| Leukocytes (× 103/mm3) | 7.14 | 7.06 | 7.86 | 7.90 |
| Neutrophils (%) | 62.63 | 61.45 | 63.75 | 58.61 |
| Eosinophils (%) | 2.56 | 3.34 | 3.81 | 3.22 |
| Basophils (%) | 0.32 | 0.55 | 0.44 | 0.22 |
| Lymphocytes (%) | 25.89 | 28.03 | 27.82 | 27.74 |
| Monocytes (%) | 6.97 | 7.20 | 7.14 | 7.88 |
Group A: Mesalamine + NAC; Group B: Mesalamine + placebo.